Intraperitoneal versus Intravenous Cisplatin in Combination with Intravenous Cyclophosphamide and Epidoxorubicin in Optimally Cytoreduced Advanced Epithelial Ovarian Cancer: A Randomized Trial of the Gruppo Oncologico Nord-Ovest-Reference-Cited by-同舟云学术

Intraperitoneal versus Intravenous Cisplatin in Combination with Intravenous Cyclophosphamide and Epidoxorubicin in Optimally Cytoreduced Advanced Epithelial Ovarian Cancer: A Randomized Trial of the Gruppo Oncologico Nord-Ovest

Published:2000-02 Issue:2 Volume:76 Page:157-162
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Gadducci Angiolo,Carnino Flavio,Chiara Silvana,Brunetti Isa,Tanganelli Lucia,Romanini Antonella,Bruzzone Milena,Conte Pier Franco

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference23 articles.

1. Theoretical and experimental bases of intraperitoneal chemotherapy;Dedrick;Semin Oncol,1985

2. Intraperitoneal chemotherapy in the management of ovarian cancer;Markman;Cancer,1993

3. Intraperitoneal therapy of ovarian cancer;Markman;Semin Oncol,1998

4. Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy;Howell;J Clin Oncol,1987

5. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma;Piver;J Clin Oncol,1988

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines;Journal of Gynecologic Oncology;2024

2. Immunological Impact of Intraperitoneal and Intravenous Chemotherapy in Ovarian Cancer, Translational Analyses of the Phase 3 Ipocc Trail;2024

3. Surgical management of peritoneal metastasis: Opportunities for pharmaceutical research;Journal of Controlled Release;2023-09

4. Epithelial ovarian cancer;DiSaia and Creasman Clinical Gynecologic Oncology;2023

5. Overview of Ovarian Cancer Chemotherapy;Advances in Diagnosis and Management of Ovarian Cancer;2022